The global drug free depression treatment demand is anticipated to increase at a moderate CAGR of around 2% to 4% during the forecast period between 2022 and 2032. Growth is attributed to the rising popularity of drug free depression treatments across the globe due to their minimum/negligible side effects.
| Report Attribute | Details |
|---|---|
| Drug Free Depression Treatment Market Projected Growth Rate (2022 to 2032) | 2% to 4% CAGR |
Depression has become one of the most commonly found mental health problems across the world, which not only affects a person emotionally but physically as well. It generally results from a complex interaction of social, psychological and biological factors. In fact, various studies have concluded that depression is a major reason behind the increasing suicide rates.
Various treatment options such as drugs and non-drug treatment are available for the treatment of depression throughout the world. Among these, drugs are commonly used options for the treatment of depression due to their fast effectiveness. Many medical professionals recommend using medication for the treatment of depression and other mental disorders.
However, most of the depression drugs are associated with several side effects including headache, sexual problems, nausea, dizziness, constipation etc. As a result, people are gradually shifting their preference towards drug free depression treatments like cognitive behavioral therapy, transcranial magnetic stimulation. This is acting as a catalyst for the growth of drug free depression treatment market and the trend is likely to continue in the future as more and more people are becoming aware about the benefits of using drug free depression treatments.
Among the drug free depression treatments, transcranial magnetic stimulation and cognitive behavioral therapy remain the most commonly adopted methods for the treatment of depression. Patients suffering from depression are opting for these treatments to get rid of the depression without developing side effects.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising prevalence of depression and anxiety due to changing lifestyle and aging, growing awareness among people regarding the availability of alternative depression options, and various benefits associated with drug free depression treatment are some of the major factors driving the growth in drug free depression treatment market.
There is no denying the fact that medication is the quickest and most effective way for relieving the symptoms and treating mental disorders like depression. However, consumption of depression drugs leads to various mild to severe side effects. Growing awareness among people regarding the adverse side effects of consuming depression drugs is gradually bringing drug free depression treatments like cognitive behavioral therapy, transcranial magnetic stimulation, herbal remedies, and guided imagery, into the spotlight.
Drug free depression treatments are effective for treating depression and several other mental disorders to a large extent. These treatments have minimum side effects which makes them ideal for adoption.
Increasing incidence of depression and other mental disorders is anticipated to continue boosting the growth of drug free depression treatment market during the forecast period. According to the World Health Organization (WHO), around 280 million people in the world have depression and this number is expected to further surge during the forthcoming years.
Similarly, various initiatives and awareness campaigns launched by government and health organizations like Anxiety and Depression Association of America about the drug free depression treatment will further propel the growth of drug free depression treatment market in future
Although drug free depression treatments are gradually gaining traction, there are various factors that are acting as restraints for market growth. Some of these factors are the lack of awareness among people about the alternative treatment options of depression and high cost of drug free depression treatments as compared to drug treatment.
Principal Consultant
North America was the largest market for drug free depression treatments in 2022 and the trend is likely to pertain during the forecast period, owing to the high levels of health awareness of people, availability of favorable reimbursement policies, and increasing adoption of drug free depression treatments across countries like the U.S. and Canada.
The U.S. remains one of the leading destinations for drug free depression treatments like cognitive behavioral therapy and transcranial magnetic stimulation due to increasing prevalence of mental health disorders. People across the country spend large amounts for the treatment of mental health problems.
Moreover, presence of a well-established healthcare sector along with increasing government initiatives to reduce the burden of mental health disorders, and growing popularity of non-medicine treatments due to minimal side effects will continue to favor the growth of drug free depression treatment market across the region.
According to Future Market Insights, Asia-Pacific is expected to emerge as the fastest growing region for drug free depression treatment market owing to the growing popularity of herbal medicine in countries like in India, Japan, and China, rising health awareness among people, and large presence of leading market players.
Emerging nations such as China and India are witnessing huge upsurge in the cases of depression and anxiety due to rapidly increasing geriatric population and lifestyle problems. This in turn is creating growth potential for drug free depression treatment market and the trend is likely to continue in the future,
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key participants present in the global drug free depression treatment market include Cleveland Clinic, Mayo Clinic, Fortis Healthcare, Assurex Health, Inc., Great Oaks Recovery Center, McLean Hospital among others.
These key players are adopting various organic and inorganic growth strategies such as partnerships, collaborations, new product launches, and acquisitions to gain a competitive edge in the market. Besides this, they are continuously launching awareness programs and campaigns to educate people about the benefits of using drug free depression treatment for mental disorders.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 2% to 4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Treatment Type, Facility Type, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; APEJ; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | Cleveland Clinic; Mayo Clinic; Fortis Healthcare; Assurex Health, Inc.; Great Oaks Recovery Center; McLean Hospital |
| Customization | Available Upon Request |
As per FMI the global drug free depression treatment market is anticipated to grow at around 2% to 4% CAGR during the forecast period.
Asia Pacific is expected to emerge as the most opportunistic market for drug free depression treatment during the forecast period.
Cleveland Clinic, Mayo Clinic, Fortis Healthcare, and Assurex Health, Inc. are some prominent drug free depression treatment providers.
Explore Healthcare Insights
View Reports
Drug Free Depression Treatment Market
